Successfully conducting a clinical trial in the UK extends beyond developing an Investigational Medicinal Product (IMP) and recruiting participants. Sponsors must also establish robust regulatory, quality, and operational processes to safeguard participant safety, ensure the integrity of clinical data, and comply with Medicines and Healthcare products Regulatory Agency (MHRA) requirements. Understanding these requirements early can help avoid costly delays and support a successful clinical development programme.
Regulatory Approval
Before a clinical trial can begin, sponsors must obtain the necessary approvals from the relevant authorities. These typically include:
- Clinical Trial Authorisation (CTA) from the MHRA
- Approval from a Research Ethics Committee (REC)
- Site-specific approvals and contracts where required
The application process requires detailed information on the investigational medicinal product, study protocol, investigator brochure, and supporting quality documentation.
Investigational Medicinal Product (IMP) Manufacturing
Any investigational medicinal product used in a clinical trial must be manufactured in accordance with Good Manufacturing Practice (GMP). This includes:
- Manufacturing under an appropriate GMP licence
- Validated manufacturing and testing processes
- Quality control testing
- Stability studies
- Comprehensive batch documentation that will be reviewed by a Qualified Person (QP)
Maintaining GMP compliance throughout the manufacturing process is essential to ensure the quality, safety, and consistency of the IMP.
Qualified Person (QP) Certification
One of the most important requirements for clinical trials involving medicinal products is QP certification.
Before an IMP can be released for use in a UK clinical trial, a Qualified Person (QP) must certify that each batch has been manufactured and tested in accordance with GMP requirements, the clinical trial application, and applicable regulations.
QP certification provides an independent assessment of product quality and helps ensure that trial participants receive investigational products that meet the required standards.
IMP Importation and Supply Chain Management
Where investigational products are manufactured outside the UK, additional controls may be required to ensure compliance with UK regulations. Sponsors must consider:
- Importation requirements
- Supply chain oversight
- Temperature-controlled distribution
- Storage and accountability procedures
- Product traceability throughout the trial
A QP can play a key role in reviewing imported product documentation and supporting compliant batch release activities.
Ongoing Quality Oversight
Clinical trial compliance does not end once the study begins. Sponsors must maintain robust quality systems to manage:
- Deviations and non-conformances
- Product complaints
- Quality investigations
- Change controls
- Product recalls, if required
Experienced QPs can provide valuable support in assessing quality events, performing risk assessments, and ensuring regulatory expectations are met throughout the study lifecycle.
Why Engage a Qualified Person Early?
Many sponsors engage QP services at an early stage of development to avoid delays during clinical trial preparation and product release. Early QP involvement can help with:
- IMP release strategy
- GMP compliance assessments
- Batch certification
- Importation requirements
- Quality documentation review
- Investigation and recall support
- Regulatory inspection readiness
By incorporating QP expertise into the clinical trial programme from the outset, sponsors can reduce compliance risks and maintain confidence in their product supply chain.
Conclusion
Successfully conducting a clinical trial in the UK requires careful planning, robust quality systems, and compliance with regulatory requirements. Qualified Person services play a critical role in ensuring investigational medicinal products are manufactured, assessed, and released in accordance with GMP and clinical trial regulations.
Whether supporting IMP certification, importation activities, or ongoing quality oversight, an experienced QP provider like HiTech Health can help sponsors navigate the complexities of clinical trial compliance and keep development programmes moving forward.
Contact our team today and schedule a call to learn more about our services for the EU and UK markets.